title: Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment.
abstract: Bacterial whole-genome sequencing (WGS) of human pathogens has provided unprecedented insights into the evolution of antibiotic resistance. Most studies have focused on identification of resistance mutations, leaving one to speculate on the fate of these mutants once the antibiotic selective pressure is removed. We performed WGS on longitudinal isolates of Acinetobacter baumannii from patients undergoing colistin treatment, and upon subsequent drug withdrawal. In each of the four patients, colistin resistance evolved via mutations at the pmr locus. Upon colistin withdrawal, an ancestral susceptible strain outcompeted resistant isolates in three of the four cases. In the final case, resistance was also lost, but by a compensatory inactivating mutation in the transcriptional regulator of the pmr locus. Notably, this inactivating mutation reduced the probability of reacquiring colistin resistance when subsequently challenged in vitro. On face value, these results supported an in vivo fitness cost preventing the evolution of stable colistin resistance. However, more careful analysis of WGS data identified genomic evidence for stable colistin resistance undetected by clinical microbiological assays. Transcriptional studies validated this genomic hypothesis, showing increased pmr expression of the initial isolate. Moreover, altering the environmental growth conditions of the clinical assay recapitulated the classification as colistin resistant. Additional targeted sequencing revealed that this isolate evolved undetected in a patient undergoing colistin treatment, and was then transmitted to other hospitalized patients, further demonstrating its stability in the absence of colistin. This study provides a unique window into mutational pathways taken in response to antibiotic pressure in vivo, and demonstrates the potential for genome sequence data to predict resistance phenotypes.
authors.affiliation: Epithelial Biology Section, GMBB, NHGRI, Bethesda, Maryland 20892, USA.
authors.forename: Evan S
authors.initials: ES
authors.lastname: Snitkin
authors.forename: Adrian M
authors.initials: AM
authors.lastname: Zelazny
authors.forename: Jyoti
authors.initials: J
authors.lastname: Gupta
authors.forename: Tara N
authors.initials: TN
authors.lastname: Palmore
authors.forename: Patrick R
authors.initials: PR
authors.lastname: Murray
authors.forename: Julia A
authors.initials: JA
authors.lastname: Segre
mesh_terms: D000151:Acinetobacter Infections / Q000188:drug therapy; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000235:genetics*; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003091:Colistin / Q000494:pharmacology* / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D015964:Gene Expression Regulation, Bacterial; D005798:Genes, Bacterial; D056084:Genetic Fitness; D016680:Genome, Bacterial; D023281:Genomics; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation; D020641:Polymorphism, Single Nucleotide
chemical_list: D000900:Anti-Bacterial Agents; D003091:Colistin
references.citation: Nat Rev Microbiol. 2010 Jun;8(6):423-35
references.pmid: 20440275
references.citation: PLoS Pathog. 2011 Nov;7(11):e1002359
references.pmid: 22102812
references.citation: Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10775-80
references.pmid: 22711808
references.citation: Bioinformatics. 2009 Jun 15;25(12):1564-5
references.pmid: 19369502
references.citation: Infect Control Hosp Epidemiol. 2011 Dec;32(12):1166-72
references.pmid: 22080654
references.citation: Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7
references.pmid: 20855724
references.citation: Antimicrob Agents Chemother. 2013 Jan;57(1):592-6
references.pmid: 23070160
references.citation: Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84
references.pmid: 17646423
references.citation: Nucleic Acids Res. 2002 Jun 1;30(11):2478-83
references.pmid: 12034836
references.citation: Nucleic Acids Res. 2006;34(20):5839-51
references.pmid: 17062630
references.citation: J Infect Dis. 2012 Dec 1;206(11):1724-33
references.pmid: 22984115
references.citation: J Clin Microbiol. 2005 Feb;43(2):903-5
references.pmid: 15695701
references.citation: J Antimicrob Chemother. 2012 Jun;67(6):1325-32
references.pmid: 22378682
references.citation: J Infect Dis. 2011 Feb 15;203(4):545-8
references.pmid: 21216865
references.citation: Nat Rev Microbiol. 2010 Apr;8(4):260-71
references.pmid: 20208551
references.citation: J Clin Microbiol. 2007 Oct;45(10):3352-9
references.pmid: 17715376
references.citation: Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
references.pmid: 12824425
references.citation: Proteomics. 2009 Mar;9(6):1632-45
references.pmid: 19253303
references.citation: J Bacteriol. 1998 Sep;180(17):4538-46
references.pmid: 9721293
references.citation: Nat Rev Microbiol. 2007 Jan;5(1):48-56
references.pmid: 17143318
references.citation: J Infect. 2011 Mar;62(3):212-7
references.pmid: 21237201
references.citation: Antimicrob Agents Chemother. 2009 Sep;53(9):3628-34
references.pmid: 19528270
references.citation: Nat Genet. 2011 Dec 18;44(1):106-10
references.pmid: 22179134
references.citation: Genome Res. 1998 Mar;8(3):195-202
references.pmid: 9521923
references.citation: N Engl J Med. 2011 Sep 8;365(10):892-900
references.pmid: 21899450
references.citation: Infect Control Hosp Epidemiol. 2009 Mar;30(3):257-63
references.pmid: 19199531
references.citation: Int J Antimicrob Agents. 2010 Mar;35(3):219-26
references.pmid: 20047818
references.citation: J Antimicrob Chemother. 2012 Jul;67(7):1607-15
references.pmid: 22441575
references.citation: Curr Opin Microbiol. 1999 Oct;2(5):489-93
references.pmid: 10508723
references.citation: Antimicrob Agents Chemother. 2011 Jul;55(7):3370-9
references.pmid: 21576434
references.citation: Bioinformatics. 2009 Aug 15;25(16):2071-3
references.pmid: 19515959
references.citation: J Antimicrob Chemother. 2011 Sep;66(9):2070-4
references.pmid: 21715434
references.citation: Nat Rev Microbiol. 2005 Mar;3(3):238-50
references.pmid: 15703760
references.citation: N Engl J Med. 2008 Mar 20;358(12):1271-81
references.pmid: 18354105
references.citation: Nat Rev Microbiol. 2007 Dec;5(12):939-51
references.pmid: 18007677
references.citation: Proc Natl Acad Sci U S A. 2007 May 29;104(22):9451-6
references.pmid: 17517606
references.citation: Structure. 1997 Jan 15;5(1):109-24
references.pmid: 9016718
references.citation: Nat Rev Microbiol. 2012 Sep;10(9):599-606
references.pmid: 22864262
references.citation: J Infect Dis. 2011 Oct 1;204(7):1146-7
references.pmid: 21881132
references.citation: Science. 2006 Jun 30;312(5782):1944-6
references.pmid: 16809538
references.citation: Cell. 2007 Mar 23;128(6):1037-50
references.pmid: 17382878
references.citation: Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13758-63
references.pmid: 21825119
references.citation: Int J Antimicrob Agents. 2011 Jun;37(6):525-30
references.pmid: 21497062
references.citation: Methods. 2000 Jan;20(1):4-17
references.pmid: 10610800
references.citation: Nature. 2009 Aug 13;460(7257):894-898
references.pmid: 19633652